414 related articles for article (PubMed ID: 34182032)
1. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
3. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions.
Tsujimura T; Takahara M; Iida O; Soga Y; Katsuki T; Fujihara M; Kawasaki D; Kozuki A; Mano T
J Vasc Surg; 2021 Jun; 73(6):1998-2008.e1. PubMed ID: 33347998
[TBL] [Abstract][Full Text] [Related]
7. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM;
J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
[TBL] [Abstract][Full Text] [Related]
8. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
10. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of the heparin-bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm.
Uhl C; Dadras A; Reichmann F; Betz T; Zorger N; Toepel I; Steinbauer M
Vascular; 2019 Oct; 27(5):553-559. PubMed ID: 30917750
[No Abstract] [Full Text] [Related]
12. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
[TBL] [Abstract][Full Text] [Related]
13. SUrgical versus PERcutaneous Bypass: SUPERB-trial; Heparin-bonded endoluminal versus surgical femoro-popliteal bypass: study protocol for a randomized controlled trial.
Lensvelt MM; Holewijn S; Fritschy WM; Wikkeling OR; van Walraven LA; Wallis de Vries BM; Zeebregts CJ; Reijnen MM
Trials; 2011 Jul; 12():178. PubMed ID: 21767371
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
15. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
Lin TC; Huang CY; Chen PL; Lee CY; Shih CC; Chen IM
J Endovasc Ther; 2018 Jun; 25(3):313-319. PubMed ID: 29673299
[TBL] [Abstract][Full Text] [Related]
16. Midterm Results of a Japanese Prospective Multicenter Registry of Heparin-Bonded Expanded Polytetrafluoroethylene Grafts for Above-the-Knee Femoropopliteal Bypass.
Shibutani S; Obara H; Matsubara K; Toya N; Isogai N; Ogino H; Watada S; Asami A; Kudo T; Kanaoka Y; Fujimura N; Harada H; Uchiyama H; Sato Y; Ohki T;
Circ J; 2020 Feb; 84(3):501-508. PubMed ID: 32062636
[TBL] [Abstract][Full Text] [Related]
17. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
Schneider JR; Verta MJ; Alonzo MJ; Hahn D; Patel NH; Kim S
Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
[TBL] [Abstract][Full Text] [Related]
18. Results of hybrid procedures for treatment of aortoiliac Trans-Atlantic Inter-Society Consensus II D lesions with self-expanding covered heparin-bonded stent grafts.
Uhl C; Betz T; Weiss B; Töpel I; Steinbauer M
J Cardiovasc Surg (Torino); 2020 Feb; 61(1):93-97. PubMed ID: 29430887
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858
[TBL] [Abstract][Full Text] [Related]
20. Twelve-Month Outcomes From the Japanese Post-Market Surveillance Study of the Viabahn Endoprosthesis as Treatment for Symptomatic Peripheral Arterial Disease in the Superficial Femoral Arteries.
Iida O; Ohki T; Soga Y; Suematsu N; Nakama T; Yamaoka T; Tobita K; Ichihashi S
J Endovasc Ther; 2022 Dec; 29(6):855-865. PubMed ID: 34905961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
